SARS-CoV-2/Influenza A/Influenza B Detection Kit (Fluorescence PCR)

For in vitro qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B nucleic acids from nasopharyngeal and oropharyngeal swab specimens. Aids in the diagnosis of suspected respiratory infections, including pneumonia and cluster cases, in individuals with symptoms of COVID-19 or influenza.

SKU Code
AENE-RT148
Approval
On request
Product Type
Assay / Kit
Status
Available

For in vitro qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B nucleic acids from nasopharyngeal and oropharyngeal swab specimens. Aids in the diagnosis of suspected respiratory infections, including pneumonia and cluster cases, in individuals with symptoms of COVID-19 or influenza.

Product typeAssay / Kit
Technology platformFluorescence PCR
Application areaRespiratory Infections

Channel

Channel Name

PCR-Mix 1

PCR-Mix 2

FAM Channel

ORF1ab gene

IVA

VIC/HEX Channel

Internal control

Internal control

CY5 Channel

N gene

/

ROX Channel

E gene

IVB

SKU codeAENE-RT148
Storage-18℃
Shelf-life12 months
Specimen Typenasopharyngeal swabs and oropharyngeal swabs
TargetSARS-CoV-2 three targets ( Orf1ab, N and E genes)/influenza A /influenza B
Ct≤38
CV≤10.0%
LoDSARS-CoV-2:300 Copies/mL influenza A virus:500 Copies/mL influenza B virus:500 Copies/mL
Specificitya) The cross test results showed that the kit was compatible with human coronavirus SARSr- CoV, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, respiratory syncytial virus A and B, parainfluenza virus 1, 2 and 3, rhinovirusA, B and C, adenovirus 1, 2, 3, 4, 5, 7 and 55, human metapneumovirus, enterovirus A, B, C and D, human cytoplasmic pulmonary virus, EB virus, measles virus Human cytomegalovirus, rotavirus, norovirus, mumps virus, varicella zoster virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycobacterium tuberculosis, Aspergillus fumigatus, Candida albicans, Candida glabrata There was no cross reaction between Pneumocystis yersini and Cryptococcus neoformans. b) Anti interference ability: select mucin (60mg/mL), 10% (V/ V) human blood, diphenylephrine (2mg/mL), hydroxymethylzoline (2mg/mL), sodium chloride (containing preservative) (20mg/mL), beclomethasone (20mg/mL), dexamethasone (20mg/mL), flunisone (20μg/mL), triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), α-Interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), pramivir (1mg/mL), lopinavir (500mg/mL), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), ceprotene (40μg/mL) Meropenem (200mg/mL), levofloxacin (10μg/mL) and tobramycin (0.6
Applicable InstrumentsApplied Biosystems 7500 Real-Time PCR Systems Applied Biosystems 7500 Fast Real-Time PCR Systems SLAN ® -96P Real-Time PCR Systems QuantStudio™ 5 Real-Time PCR Systems LightCycler ® 480 Real-Time PCR system LineGene 9600 Plus Real-Time PCR Detection System MA-6000 Real-Time Quantitative Thermal Cycler BioRad CFX96 Real-Time PCR System BioRad CFX Opus 96 Real-Time PCR System
ApprovalOn request
DocumentsDatasheet, IFU, SDS, COA / conformance, origin, and export documents where available

FAQ

What should be confirmed before quotation?

Sample context, collection method, and extraction workflow should be confirmed before final kit selection.

Which documents can be requested?

Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.

Can the format be adjusted for different workflows?

Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.

Send the essentials for a useful first reply.

Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-RT148 to the right quote or sample discussion.